Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaporized Cannabis in Chronic, Treatment-Resistant PTSD
NCT02517424Phase 2Completed
- Sponsor
- Tilray
- Start
- Feb 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabis in post-traumatic stress disorder (PTSD), sponsored by Tilray. Started Feb 2017; status: completed.
02
Drugs
cannabis
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02517424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02517424.